Main Session: A Deeper Dive into Advanced and Future Directions in Treating Patients with Acute Myeloid Leukemia

What is the clinical relevance of FLT3 and IDH2 mutations in AML?

Sandy Kurtin, PhDc, ANP-C, AOCN

Sandy Kurtin, PhDc, ANP-C, AOCN, on treating patients with AML.

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here